Complete Remission of Cavin-4 Immunoglobulin G Rippling Muscle Disease After Rituximab Therapy

Key Points

• This report aims to illustrate the effects of rituximab therapy on cavin-4 immunoglobulin G rippling muscle disease.
• Case report of a 65-year-old man
• Administration of rituximab therapy
• Monitoring clinical outcomes post-treatment.
• The patient achieved complete remission of rippling muscle disease
• Significant improvement in muscle function and symptoms noted after therapy.